The high throughput screening market is projected to reach US$ 28,255.71 million in 2028 from US$ 15,997.47 million in 2020. The market is estimated to grow with a CAGR of 8.5% from 2021 to 2028.
The high throughput screening market is projected to reach US$ 28,255.71 million in 2028 from US$ 15,997.47 million in 2020. The market is estimated to grow with a CAGR of 8.5% from 2021 to 2028.
High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are extensively used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of a large number of molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can quickly be screened in a cost-effective way. HTS is a useful tool for assessing for instance pharmacological targets, pharmacologically profiling agonists, and antagonists for receptors (such as GPCRs) and enzymes. Factors such as increase in investment in research & development by the pharmaceutical and biotechnology industry and the introduction of technologically advanced products in the high throughput screening market are expected to boost the market growth over the years. However, the high cost of high-throughput screening and lack of trained professionals, and complexity in assay development are likely to hamper the growth of the market in the coming years.
To get sample Copy of the report, along with the TOC, Statistics @ https://www.theinsightpartners.com/sample/TIPBT00002085/
Here we have listed the top high throughput screening Market companies
Agilent Technologies, Inc.; Axxam S.P.A.; Eurofins Scientific; Corning Incorporated; Molecular Devices, LLC.; Hamilton Company; Merck Group; Perkinelmer, Inc.; Tecan Group; and Thermo Fisher Scientific Inc. are among the leading companies operating in the high throughput screening market.
Based on product and service, the high throughput screening market is categorized into consumables, instruments, accessories, software, and services. In 2021, the consumables segment held the largest share of the market and is expected to witness the fastest CAGR during the forecast period. Wide ranges of consumables are used in almost every step of an HTS assay. The selection of these consumable materials is highly dependent on the instrument types that will be employed to perform the assay and other budgetary constraints.
Microtiter plates, disposable tips, dispenser tubing cartridges and cell culture tools are some examples of consumables that come in direct contact with the assay reagents. Therefore, these products need to be selected with caution and kept consistent throughout the course of the assay validation and the screening endeavor to achieve maximum data reproducibility. HTS technologies are being adopted beyond the traditional geographic markets of Europe and North America. New and existing HTS laboratories in Asia and the rest of the world are increasing their spending on equipment and consumables for HTS.
Increase in Investment in Research and Development by Pharmaceutical and Biotechnology Industry
An increase in R&D investments by pharmaceutical and biotechnology companies and extensive drug pipelines for the treatment of various chronic diseases such as cancer, cardiovascular disorders, metabolic disorders, immunological disorders, and neurological disorders, are the prominent drivers for the high throughput screening market. Several big and small pharmaceutical companies are engaged in the development and manufacturing of new and novel molecules for various life-threatening conditions. This has led to the adoption of automated high-throughput screening (HTS) techniques to screen huge chemical libraries to meet the needs of ever-increasing drug target molecules. For instance, an automated high throughput screening system can screen around 10,000 to 100,000 target compounds in a single day.
Pharma and biotech companies have substantially invested in high throughput screening techniques in the past decade. For instance, the famous alliance of Millennium Pharmaceuticals, Inc. and Bayer AG, has successfully discovered 18 novel drug targets and brought four of them into high throughput screening in just less than eight months. The alliance is adopting a novel production approach, based on genomics research, to get molecules into clinical trials as quickly as possible. High-throughput screening has been regarded as a key technology in the drug discovery process. For instance, more than 60% of Boehringer Ingelheim’s fully developed lead structure optimization programs are due to the successful implementation of HTS. More than 2.5 billion US dollars are annually spent on HTS products and HTS services in the US alone. Large pharmaceutical companies invest up to US$ 35 million annually in screening technologies. The major proportion of these investments goes into the development of new assays.
High Throughput Screening Market – by Product and Service
- Consumables
- Reagents and Assay Kits
- Laboratory Equipment
- Instruments
- Liquid Handling Systems
- Detection Systems
- Accessories
- Software
- Services
High Throughput Screening Market – by Technology
- Cell-Based Assays
- Lab-On-A-Chip
- Ultra-High-Throughput Screening
- Bioinformatics
- Label-Free Technology
High Throughput Screening Market – by Application
- Drug Discovery
- Biochemical Screening
- Life Sciences Research
- Other Applications
High Throughput Screening Market – by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations (CRO)
Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPBT00002085/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com